Zimbabwe introduces better HIV drug

Zimbabwe has introduced a new user-friendly Anti-Retroviral Treatment (ARV) drug which also increases adherence to treatment.

The new combination drug called Tenofovir, Lamivudine, Efavirenz - also known as TLE400 - is said to be the current treatment of HIV/Aids.

The distributors of the drug in Zimbabwe, New Avakash International, said at the weekend that they had already acquired substantial stocks for both the private and public health sector.

This target seeks to have 90% of all the people with HIV known status, 90% of diagnosed people being on treatment and 90% of those on treatment having suppressed levels of the virus in their bodies by 2020.